Declaring a Truce with Our Microbiological Frienemies
News Mar 27, 2013
Researchers have historically focused on microbes in the body as primarily pathogens that must be fought, said Eric Harvill, professor of microbiology and infectious disease. However, he said that recent evidence of the complex interaction of the body with microbes suggests a new interpretation of the relationship.
"Now we are beginning to understand that the immune system interacts with far more beneficial bacteria than pathogens," said Harvill. "We need to re-envision what the true immune system really is."
Harvill said that this reinterpretation leads to a more flexible approach to understanding how the immune system interacts with microbes. This approach should balance between defending against pathogens and enlisting the help of beneficial microbes.
While the role that some bacteria play in aiding digestion is better known, microbes assist in improving body functions, including strengthening the immune system and responding to injuries.
In some cases, attacking pathogens can harm the beneficial effects microbes have on immune system, according to Harvill. For example, patients on antibiotics have an increased risk of contracting yeast infections and MRSA.
"Viewing everything currently considered immunity, including both resistance and tolerance, as aspects of a complex microbiome management system that mediates interactions with the sea of microbes that surround us, many of which are beneficial, can provide a much more positive outlook and different valuable perspectives," Harvill said.
The system that includes bacteria and other microbes in the human body, or the microbiome, is much larger and more integrated into human health than most people suspect, according to Harvill.
"The human body has ten times more bacterial cells than human cells," said Harvill.
Adding to the complexity is the adaptive capacity of the human immune system. The immune system can develop antibodies against certain pathogens, which it can reuse when threatened by future attacks from the same pathogen.
Harvill, who described his alternative viewpoint in the latest issue of mBio, said that some researchers have not yet accepted this broader approach to the immune system.
"Among immunologists or microbiologists this is an alien concept," said Harvill. "It's not part of how we have historically looked at the immune system, but it's a useful viewpoint."
Other researchers who study plant and nonhuman biology are already starting to embrace the concept. For example, plant biologists are beginning to recognize that viruses can help plants resist drought and heat.
"Within nonhuman immunology, this is not an alien concept because they have seen many examples of beneficial relationships between the host and its microbial commensals," Harvill said.
Harvill said adopting this new perspective could be the first step toward new medical treatments.
"This new viewpoint suggests new experiments and results will published," said Harvill. "And, hopefully, the concept becomes more and more mainstream as supporting evidence accumulates."
H7N9 Influenza Vaccine Clinical Trials CommenceNews
Two new clinical trials testing an experimental vaccine to prevent influenza caused by an H7N9 influenza virus are now enrolling volunteers at sites across the United States. The Phase 2 studies will test different dosages of the inactivated influenza vaccine candidate as well as different vaccination schedules. The studies also will evaluate whether an adjuvant boosts the immune responses of people receiving the vaccine.
Study Extends Potential of Personalized Cell-based ImmunotherapiesNews
New methods developed for the study could be applied to devise personalized, cell-based immunotherapies for epithelial ovarian cancer or other types of tumorsREAD MORE
Alternative to Antibiotics: Antibody Approach for Treating Multidrug-Resistant Bacterial InfectionsNews
Researchers are developing a promising alternative to antibiotic treatment for infections caused by Klebsiella pneumoniae bacteria resistant to carbapenem antibiotics. The approach uses antibodies to target the K. pneumoniae protective capsule polysaccharide.READ MORE
Comments | 0 ADD COMMENT
7th International Conference on Bacteriology and Infectious Diseases
Jun 04 - Jun 05, 2018